摘要
最近的研究表明 ,虽然病原性血管因子很多 ,但在释放或受体水平 ,抑制专一性血管形成因子这一策略 ,可能成为安全、有效地治疗由血管形成介导的疾病的方法基础。生理性血管形成对血管的再生、成长和修复是至关重要的 ;而病理性血管形成则维系着血管疾病、肿瘤和致炎性疾病的发展进程。血管形成因子的种类有多种 ,都间接或直接作用于内皮细胞 ,这就说明内皮细胞对血管形成的影响尤为重要 ,这一作用靶点为一些与病理性血管形成有关的人类疾病提供了新的治疗策略。目前 。
Recent evidence suggests that, in spite of the redundancy of angiogenic factors involved in pathological angiogenesis , strategies aimed at inhibiting specific endothelial cell angiogenic factors at their release or receptor level may form the basis for effective and safe treatment of angiogenic mediated disease processes. Physiologic angiogenesis is fundamental to reproduction, development and repair. Pathological angiogenesis sustains the progression of many neoplastic and proinflammatory diseases. And endothelial cell is an important target especially for the angiogenesis. The target represents a novel strategy for the treatment of the human disorders where pathological angiogenesis is involved.
出处
《中国药理学通报》
CAS
CSCD
北大核心
2002年第4期361-364,共4页
Chinese Pharmacological Bulletin
基金
国家重点基础研究发展规划项目 (国家 973计划 :G19980 5 112 )
